Formic Acid

Formic Acid

SCHEMBL865074

CC(Nc1ncnc2sccc12)c1cc2cccc(Cl)c2nc1NCc1cn(C)cn1.O=CO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 3/20 0.39
NOD1 Q9Y239 3/20 0.39
RAB9A P51151 2/20 0.39
PIK3CD O00329 4/20 0.37
FADS1 O60427 1/20 0.35
FDPS P14324 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
AURKA O14965 1/20 0.33
RPS6KB1 P23443 1/20 0.33
AURKB Q96GD4 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
PIK3R2 O00459 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL865075 1.00 TNF (0.39) TNFNOD1RAB9APIK3CDFADS1
Formic Acid SCHEMBL863792 0.84 PIK3CD (0.40) PIK3CDMKNK2PIK3R2PIK3CGEGFR
Formic Acid SCHEMBL863791 0.84 PIK3CD (0.40) PIK3CDMKNK2PIK3R2PIK3CGEGFR
Formic Acid SCHEMBL865073 0.83 RAB9A (0.39) TNFNOD1RAB9APIK3CDFADS1
SCHEMBL863479 0.79 RAB9A (0.45) TNFNOD1RAB9APIK3CDFADS1
SCHEMBL863478 0.79 RAB9A (0.45) TNFNOD1RAB9APIK3CDFADS1
Hydrochloric Acid SCHEMBL864071 0.74 IRAK4 (0.38) PIK3CDRPS6KB1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL864070 0.74 IRAK4 (0.38) PIK3CDRPS6KB1ALDH1A1LMNA
SCHEMBL865314 0.71 RAB9A (0.42) TNFNOD1RAB9APIK3CDFADS1
SCHEMBL14574704 0.71 TNF (0.40) TNFNOD1RAB9APIK3CDFADS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8513284-B2 Fused pyridine and pyrazine derivatives as kinase inhibitors UCB PHARMA, S.A. (BE) 2013-08-20 US disclosed
US-20120077815-A1 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors UCB PHARMA S.A. (BE) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077815-A1 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors PDPK1, PDXK, PIK3CA TNF 1114/4885NOD1 374/4885RAB9A 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.